Byrna Technologies Inc. (BYRN)
Byrna Technologies Inc. specializes in non-lethal self-defense solutions, offering innovative products like the Byrna HD, a handheld personal security device that shoots non-lethal projectiles. The company’s mission is to provide consumers with safe and effective alternatives for personal protection without the need for firearms.
Byrna’s growing range of self-defense tools and accessories, along with its commitment to safety and innovation, positions it as a leader in the non-lethal defense market. The company’s focus on expanding its customer base globally supports its long-term growth strategy. Chart
Cava Group, Inc. (CAVA)
Cava Group, Inc. is a fast-casual restaurant chain that offers Mediterranean-inspired cuisine made from fresh, healthy ingredients. The company focuses on providing a customizable dining experience, allowing customers to create their own meals using a variety of Mediterranean dishes and toppings.
Cava has expanded its footprint rapidly, both through its physical restaurants and retail products. With a growing demand for healthy dining options, Cava continues to attract health-conscious consumers seeking flavorful and nutritious meals. Chart
CareDx, Inc. (CDNA)
CareDx, Inc. is a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated diagnostic solutions for transplant patients. The company’s innovative testing methods are designed to improve post-transplant care and enhance patient outcomes.
CareDx is a leader in transplant diagnostics, offering solutions that help clinicians monitor transplant rejection and manage long-term patient health. Its commitment to improving transplant care through advanced diagnostics drives its growth in the healthcare sector. Chart
Corvus Pharmaceuticals, Inc. (CRVS)
Corvus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to developing immune-oncology therapies that target cancer and other serious diseases. The company’s research focuses on developing therapies that modulate the immune system to improve cancer treatment efficacy.
With a strong pipeline of innovative cancer therapies, Corvus Pharmaceuticals is well-positioned to address unmet needs in oncology. The company continues to advance its research in immunotherapy to bring new solutions to patients battling cancer. Chart